SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+10.37%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$2.43B
AUM Growth
+$2.43B
(+4.8%)
Cap. Flow
+$27.8M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
44.17%
Holding
71
New
12
Increased
26
Reduced
26
Closed
7
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$43.8M |
| 2 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$43.1M |
| 3 |
Thermo Fisher Scientific
TMO
|
$32.3M |
| 4 |
FRX
FOREST LABORATORIES INC
FRX
|
$24.9M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$24.6M |
Top Sells
| 1 |
Perrigo
PRGO
|
$50.2M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$24.8M |
| 3 |
Merck
MRK
|
$24.2M |
| 4 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$22.7M |
| 5 |
CELG
Celgene Corp
CELG
|
$19.6M |
Sector Composition
| 1 | Healthcare | 92.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amgen
AMGN
$155B
| $173M | 7.13% | 1,405,062 +142,429 | +11% | +$17.6M |
|
2
Biogen
BIIB
$19.4B
| $164M | 6.75% | 536,393 -8,182 | -2% | -$2.5M |
|
3
Gilead Sciences
GILD
$140B
| $146M | 6% | 2,057,416 +115,843 | +6% | +$8.21M |
|
|
4
Thermo Fisher Scientific
TMO
$186B
| $94.4M | 3.89% | 785,500 +268,900 | +52% | +$32.3M |
|
5
Regeneron Pharmaceuticals
REGN
$61.5B
| $92.3M | 3.8% | 307,400 +31,400 | +11% | +$9.43M |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $90.3M | 3.71% | 1,276,741 +44,583 | +4% | +$3.15M |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $83.4M | 3.43% | 548,008 +51,700 | +10% | +$7.87M |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $79M | 3.25% | 566,236 -140,200 | -20% | -$19.6M |
|
|
9
Teva Pharmaceuticals
TEVA
$21.1B
| $76.2M | 3.13% | 1,441,992 +828,343 | +135% | +$43.8M |
|
10
Incyte
INCY
$16.5B
| $75.1M | 3.09% | 1,403,160 +217,900 | +18% | +$11.7M |
|
11
Halozyme
HALO
$8.56B
| $68M | 2.8% | 5,355,488 +654,126 | +14% | +$8.31M |
|
12
Viatris
VTRS
$12.3B
| $67.9M | 2.79% | 1,390,697 +21,990 | +2% | +$1.07M |
|
13
BioMarin Pharmaceuticals
BMRN
$11.2B
| $63.3M | 2.6% | 927,406 +213,600 | +30% | +$14.6M |
|
|
AGN
14
DELISTED
ALLERGAN INC
AGN
| $61.6M | 2.53% | 496,548 -64,785 | -12% | -$8.04M |
|
|
AGN
15
DELISTED
Allergan plc
AGN
| $60.5M | 2.49% | 293,950 -13,200 | -4% | -$2.72M |
|
|
KERX
16
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $60.3M | 2.48% | 3,537,590 +778,640 | +28% | +$13.3M |
|
|
SHPG
17
DELISTED
Shire pic
SHPG
| $58.1M | 2.39% | 391,197 -77,562 | -17% | -$11.5M |
|
18
Innoviva
INVA
$1.29B
| $57.3M | 2.36% | 1,851,088 -122,100 | -6% | -$3.78M |
|
19
Ironwood Pharmaceuticals
IRWD
$214M
| $57.2M | 2.35% | 4,642,182 -442,817 | -9% | -$5.46M |
|
|
IMGN
20
DELISTED
Immunogen Inc
IMGN
| $54.1M | 2.23% | 3,623,786 +110,504 | +3% | +$1.65M |
|
|
OMED
21
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $45.3M | 1.87% | 1,347,642 +127,636 | +10% | +$4.29M |
|
|
AEGR
22
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $43.1M | 1.77% | +934,100 | New | +$43.1M |
|
|
NPSP
23
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $42.2M | 1.73% | 1,408,729 -366,190 | -21% | -$11M |
|
|
GEVA
24
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $38.6M | 1.59% | 465,145 -273,860 | -37% | -$22.7M |
|
25
Ionis Pharmaceuticals
IONS
$6.79B
| $38.1M | 1.57% | 882,101 -340,300 | -28% | -$14.7M |
|